During the past decade, Allergy Associates of Tucson conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Allergy Associates of Tucson" are "Asthma" (2 trials) and "History of IgE Dependent Reaction to a Penicillin Product" (1 trials). Many other conditions were trialed in "Allergy Associates of Tucson" in a lesser frequency.

Most popular intervention types in "Allergy Associates of Tucson" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Lebrikizumab" (1 trials), "Omalizumab" (1 trials), "Penicillin skin test kit" (1 trials), "Placebo" (1 trials) and "Standard of Care" (1 trials). Other intervention names were less common.

The vast majority of trials in "Allergy Associates of Tucson" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Allergy Associates of Tucson". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Allergy Associates of Tucson, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Allergy Associates of Tucson, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".